Gland Pharma Limited (GLAND)
₹1,782.7
INR-9.60(-0.54%)
As of June 27, 2025 9:44:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹29529.22 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹26799.01 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
42.30
Forward P/E
Price to Earnings ratio based on forecasted earnings
27.57
PEG Ratio
Price/Earnings to Growth ratio
27.57
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
5.26
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
65.76%
Operating Margin
Operating income as a percentage of revenue
17.67%
Return on Equity
Net income as a percentage of shareholders' equity
7.82%
Revenue (TTM)
Total revenue over trailing 12 months
₹5616.50 Cr-7.3%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1482.53 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹42.37-3.1%
Balance Sheet
Total Cash
Total cash and short-term investments
₹3049.83 Cr
Total Debt
Total short-term and long-term debt
₹313.73 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
3.43%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1277.8 - ₹2220.95
Beta
Measure of stock's volatility compared to the market
0.32
Shares Outstanding
Total number of shares issued by the company
₹16.48 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.01%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
1.01%
Payout Ratio
Percentage of earnings paid as dividends
47.17%
